Finally, in ADAMTS13 −/− mouse models of TTP, the use of a new rADAMTS13 product (BAX930) [123] demonstrated both prophylactic and therapeutic efficacies, with a favorable preclinical profile, supporting future clinical development. The gene discussed is ADAMTS13; the disease is thrombotic thrombocytopenic purpura.